Exercise as Maintenance Therapy in Advanced Lung Cancer

T
Tarah Ballinger, MD

Primary Investigator

Recruiting
18 years - 100 years
All
Phase N/A
86 participants needed
2 Locations

Brief description of study

What is the purpose of this study?
 
The purpose of this study is to examine how a multimodality (having or using a variety of methods to do something) exercise intervention may improve survival, function, and quality of life in participants with advanced lung cancer.

 

Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive Cancer Center, please contact:
IU Clinical Trials Office 
Phone: (317) 278-5632

Detailed description of study

What will happen during the study?

This study is a randomized control trial at a single institution comparing advanced lung cancer patients undergoing supervised home-based exercise program versus usual care. The intervention is a supervised home-based exercise program that will be coordinated by the MOVE program. The regimen will be 12 weeks in duration, three times a week, and administered by a trained professional virtually.

Participants will be randomized 1:1 to the exercise or usual care arm. Participants will be stratified on baseline frailty by the SPPB.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Lung Cancer
  • Age: 18 years - 100 years
  • Gender: All

Inclusion Criteria:

  1. Age ≥ 18 years
  2. Known diagnosis of locally advanced (stage III) or metastatic NSCLC
  3. Patient is currently receiving maintenance immunotherapy for at least 1 month and planned for at least 3 additional months of therapy
    1. Patients receiving maintenance therapy refers to patients with stable disease or partial response to therapy, including patients who have had a history of disease progression but are currently stable or responding to a different therapy
    2. Patients previously receiving chemotherapy are eligible as long as at least one month has elapsed since completing chemotherapy. Those currently receiving chemotherapy are not eligible.
  4. Patient is willing and able to participate in a supervised home-based exercise program as determined by the MOVE program

    a.Participants must have internet access and equipment to participate in virtual exercise

  5. ECOG performance status of 0-2

Exclusion Criteria:

  1. Already meeting exercise guidelines and participating in at least 150 minutes of moderate or vigorous exercise per IPAQ
  2. Unable to participate in the supervised home-based exercise program as determined by the MOVE program
  3. Medical co-morbidities that preclude patient from participating in supervised exercise, including but not limited to:
    • Advanced heart failure
    • Advanced respiratory disease requiring home oxygen use
    • Uncontrolled psychiatric disorders
    • History of fragility fracture

Updated on 08 May 2025. Study ID: CTO-IUSCCC-0865, 22513

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center